Privi Biotechnologies Private Limited - Company Profile

It is a life sciences private limited company based in Navi Mumbai, Maharashtra, India, established in 1985.
1985 Navi Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Privi Biotechnologies Private Limited

Privi Biotechnologies Private Limited, a active private limited company, was established on 20 September 1985 in Navi Mumbai, Maharashtra, India. Engaging in biotechnology within the professional, scientific and technical sector, it holds CIN: U74220MH1985PTC037534. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹40.00 Cr and a paid-up capital of ₹36.27 Cr.

Formerly known as Prime Machine Company Private Limited. It upholds a compliant status. Employing 38 professional, Its leadership includes Bhaktavatsala Rao Doppalapudi (Managing Director), Narayan Sreenivasan Iyer (Cfo), Mahesh Purshottam Babani (Director). Past directors included Bhaktavatsala Rao Doppalapudi, Nimisha Paresh Shah, Ramesh Vishanlal Kathuria. It holds ₹8.75 M open charges and ₹22.20 Cr settled loans. Its latest AGM occurred on 18 June 2025, with the balance sheet filed on 31 March 2025. It is based at Privihousea-71Ttc,Thanebelapurroad,Nearkoparkhairanerailwaystation,, Navi Mumbai, Maharashtra, 400709.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74220MH1985PTC037534

  • Registration Number

    037534

  • Incorporation Date

    20 September 1985

  • Authorized Capital

    ₹40.00 Cr

  • Paid-Up Capital

    ₹36.27 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 40.00 Cr
  • Paid Up Capital ₹ 36.27 Cr
  • Company Age 40 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 8.75 M
  • Satisfied Charges ₹ 22.20 Cr
  • Revenue Growth **** 21.08%
  • Profit Growth **** 67.29%
  • Ebitda **** 113.03%
  • Net Worth -3.66%
  • Total Assets -3.59%
Company report

Privi Biotechnologies Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Privi Biotechnologies Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Privi Biotechnologies Private Limited?
Current Directors
Name Designation Appointment Date Status
Bhaktavatsala Rao Doppalapudi Managing Director 06 Aug 2011 Current
Narayan Sreenivasan Iyer Cfo 14 Mar 2019 Current
Mahesh Purshottam Babani Director 06 Aug 2011 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 14 Mar 2019 Past
Pramod Abcsdd Director 06 Aug 2011 Past
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Director 16 Feb 2018 Past
Pramod Abcsdd Director 05 Jul 2012 Past
Pramod Abcsdd Director 05 Jul 2012 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Privi Biotechnologies.

Privi Biotechnologies Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 21.08% increase. The company also saw a substantial improvement in profitability, with a 67.29% increase in profit. The company's net worth dipped by a decrease of 3.66%.

Privi Biotechnologies revenue growth over time
Privi Biotechnologies profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 21.08%
*******
*******
*******
*******
Revenue from Operations
*******
 22.06%
*******
*******
*******
*******
Total Assets
*******
 -3.59%
*******
*******
*******
*******
Profit or Loss
*******
 67.29%
*******
*******
*******
*******
Net Worth
*******
 -3.66%
*******
*******
*******
*******
EBITDA
*******
 113.03%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Privi Biotechnologies?

In 2023, Privi Biotechnologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹8,750,000.00

Satisfied Charges

₹222,041,465.76

Charges Breakdown by Lending Institutions
  • Others : 0.88 Cr
Latest Charge Details
Date Lender Amount Status
30 Mar 2016 Others ₹8.75 M Open
24 Jul 2018 Others ₹4.20 Cr Satisfied
03 Nov 2014 Rbl Bank Limited ₹15.00 Cr Satisfied
14 Feb 2006 State Bank Of Hyderabad ₹3.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Privi Biotechnologies?

Privi Biotechnologies has a workforce of 38 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Privi Biotechnologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Privi Biotechnologies's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Privi Biotechnologies
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Privi Biotechnologies Private Limited last Annual general meeting of members was held on 18 Jun 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Privi Biotechnologies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.

  • Director Appointment

    Progress on Ashwini Chandrakant Vichare was appointed as a Company Secretary was appointed as a Company Secretary on 30 Jan 2023 & has been associated with this company since 3 years 17 days . was documented.

  • Charges

    The activity A charge registered on 24 Jul 2018 via Charge ID 100197850 with Others was fully satisfied on 17 Jun 2019. was completed.

  • Director Appointment

    Progress on Narayan Sreenivasan Iyer was appointed as a CFO was appointed as a CFO on 14 Mar 2019 & has been associated with this company since 6 years 11 months . was documented.

  • Director Appointment

    Progress on Narayan Sreenivasan Iyer was appointed as a CFO was appointed as a CFO on 14 Mar 2019 & has been associated with this company since 6 years 11 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Privi Biotechnologies Private Limited?

The CIN of Privi Biotechnologies Private Limited is U74220MH1985PTC037534.

Where is Privi Biotechnologies Private Limited headquartered?

Privi Biotechnologies Private Limited is headquartered at Privihousea-71Ttc,Thanebelapurroad,Nearkoparkhairanerailwaystation,, Navi Mumbai, Maharashtra, 400709.

When was Privi Biotechnologies Private Limited incorporated?

Privi Biotechnologies Private Limited was incorporated on 20 September 1985.

Who are the current directors of Privi Biotechnologies Private Limited?

The current directors of Privi Biotechnologies Private Limited are

What is the primary industry of Privi Biotechnologies Private Limited?

The primary industry of Privi Biotechnologies Private Limited is Professional, Scientific And Technical.

Is Privi Biotechnologies Private Limited a listed company?

Privi Biotechnologies Private Limited is unlisted.

What is the capital structure of Privi Biotechnologies Private Limited?

The authorized capital of Privi Biotechnologies Private Limited is ₹40.00 Cr, and the paid-up capital is ₹36.27 Cr.

What is the compliance status of Privi Biotechnologies Private Limited?

The compliance status of Privi Biotechnologies Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available